Table 4.
Variable | B | Exp(B) | p-value | 95% CI for Exp(B) |
---|---|---|---|---|
Model 1α | ||||
Activin A (ng/ml) | 3.62 | 37.3 | 0.21 | 0.13 – 10962 |
Model 1b | ||||
Follistatin (ng/ml) | 2.12 | 8.3 | 0.063 | 0.89 – 78.1 |
Model 2 | ||||
Activin A (ng/ml) | 4.39 | 80.3 | 0.21 | 0.08 – 77055 |
Follistatin (ng/ml) | 2.36 | 10.6 | 0.053 | 0.97 – 114 |
Model 3 | ||||
Activin A (ng/ml) | 3.85 | 46.8 | 0.16 | 0.22 – 9883 |
Follistatin (ng/ml) | 2.77 | 16.0 | 0.046 | 1.06 – 242 |
Gender (0: men; 1: women) | 1.25 | 3.48 | 0.235 | 0.44 – 27.3 |
Model 4 | ||||
Activin A (ng/ml) | 3.73 | 41.6 | 0.16 | 0.22 – 7911 |
Follistatin (ng/ml) | 2.75 | 15.6 | 0.044 | 1.07 – 227 |
Gender (0: men; 1: women) | 1.09 | 2.98 | 0.32 | 0.35 – 25.3 |
Age (years) | 0.03 | 1.0 | 0.65 | 0.92 – 1.14 |
Model 5a | ||||
Activin A (ng/ml) | −0.17 | 0.8 | 0.97 | 0 – 16165 |
Follistatin (ng/ml) | 2.83 | 17.0 | 0.038 | 1.17 – 247 |
Gender (0: men; 1: women) | 1.38 | 4.0 | 0.27 | 0.34 – 46.2 |
Age (years) | 0.04 | 1.0 | 0.53 | 0.93 – 1.2 |
BMI (kg/m2) | 0.05 | 1.0 | 0.65 | 0.86 – 1.3 |
Model 5b | ||||
Activin A (ng/ml) | −0.16 | 0.9 | 0.97 | 0 – 7088 |
Follistatin (ng/ml) | 2.73 | 15.3 | 0.050 | 1.00 – 233 |
Gender (0: men; 1: women) | 1.39 | 4.0 | 0.26 | 0.36 – 44.6 |
Age (years) | 0.04 | 1.0 | 0.50 | 0.93 – 1.16 |
Waist circumference (cm) | 0.02 | 1.0 | 0.56 | 0.95 – 1.11 |
Model 5c | ||||
Activin A (ng/ml) | 5.32 | 204.6 | 0.19 | 0.07 – 612686 |
Follistatin (ng/ml) | 3.10 | 22.2 | 0.054 | 0.95 – 516 |
Gender (0: men; 1: women) | 1.50 | 4.49 | 0.28 | 0.30 – 66.6 |
Age (years) | 0.03 | 1.0 | 0.64 | 0.92 – 1.14 |
Leptin (ng/ml) | −0.02 | 1.0 | 0.60 | 0.91 – 1.06 |
SS was rated as 0 and NASH as 1 within dependent variable.
Abbreviations:: BMI, body mass index; HOMA-IR, homeostasis model of assessment insulin resistance, NASH, nonalcoholic steatohepatitis; SS, simple steatosis.